Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | NPC1 | O15118 | 2/20 | 0.69 |
| ▸ | RAB9A | P51151 | 2/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.55 |
| ▸ | WNT3A | P56704 | 4/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2787821 | 0.98 | HPGD (0.73) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL9046710 | 0.98 | HPGD (0.73) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL8972518 | 0.98 | HPGD (0.73) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL3183371 | 0.98 | HPGD (0.73) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL23859828 | 0.98 | HPGD (0.73) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL3176357 | 0.95 | LMNA (0.71) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL815576 | 0.89 | HPGD (0.61) | HPGDLMNAALDH1A1MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL30785213 | 0.88 | HPGD (0.64) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL28446591 | 0.87 | HPGD (0.58) | HPGDLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL3177576 | 0.87 | LMNA (0.77) | HPGDLMNAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3696200-B1 | PHOTORESPONSIVE HIGH-MOLECULAR WEIGHT MATERIAL, ADHESIVE, TONER, AND IMAGE FORMING METHOD | KONICA MINOLTA INC (JP) | 2024-08-28 | — | — | EP | disclosed |
| US-12037531-B2 | Photoresponsive high-molecular weight material, adhesive, toner, and image forming method | Konica Minolta, Inc. (JP) | 2024-07-16 | — | — | US | disclosed |
| US-7659411-B2 | Process for producing 2-acylthiophene compound | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2010-02-09 | — | — | US | disclosed |
| CN-100455578-C | Process for producing 2-acylthiophene compound | SUMITOMO SEIKA CHEMICALS (JP) | 2009-01-28 | — | — | CN | disclosed |
| US-7345079-B2 | Treatment of disorder related to low cyclic GMP levels | YUNG SHIN PHARMACEUTICALS INDUSTRIAL CO., LTD (TW) | 2008-03-18 | — | — | US | disclosed |
| US-20070149787-A1 | Process for producing 2-acylthiophene compound | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| CN-1886396-A | Process for producing 2-acylthiophene compound | SUMITOMO SEIKA CHEMICALS (JP) | 2006-12-27 | — | — | CN | disclosed |
| EP-1695972-A1 | PROCESS FOR PRODUCING 2-ACYLTHIOPHENE COMPOUND | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20030220385-A1 | Treatment of disorder related to low cyclic GMP levels | YUNG SHIN PHARMACEUTICALS INDUSTRIAL CO., LT.D (TW) | 2003-11-27 | — | — | US | disclosed |
| US-6387942-B2 | PYRAZOLYL COMPOUND; ANTICOAGULANTS, ANTIPROLIFERATIVE AGENT | YUNG SHIN PHARMACEUTICAL IND. CO. LTD (TW) | 2002-05-14 | — | — | US | disclosed |
| EP-0364923-B1 | MESOMORPHIC COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING SAME AND LIQUID CRYSTAL DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0500072-A1 | Liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1992-08-26 | — | — | EP | disclosed |
| EP-0499252-A1 | Liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1992-08-19 | — | — | EP | disclosed |
| US-5118441-A | AC stabilization effect; good display and response | CANON KABUSHIKI KAISHA (JP) | 1992-06-02 | — | — | US | disclosed |
| US-5116530-A | Ferroelectrical optical apparatus containing thiophene groups | CANON KABUSHIKI KAISHA (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0459406-A1 | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1991-12-04 | — | — | EP | disclosed |
| EP-0458347-A2 | Liquid crystal composition and display device using same | CANON KABUSHIKI KAISHA (JP) | 1991-11-27 | — | — | EP | disclosed |
| EP-0392510-A1 | Mesomorphic compound, liquid crystal composition and liquid crystal device using same | CANON KABUSHIKI KAISHA (JP) | 1990-10-17 | — | — | EP | disclosed |
| EP-0364923-A2 | Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same | CANON KABUSHIKI KAISHA (JP) | 1990-04-25 | — | — | EP | disclosed |
| US-4467102-A | RACEMIC MODIFICATION WITH BRUCINE | UBE INDUSTRIES, LTD. (JP) | 1984-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220385-A1 | Treatment of disorder related to low cyclic GMP levels | PDE7A, PDE2A, PDE4A | HPGD 226/4885LMNA 1031/4885ALDH1A1 1728/4885 |
| US-20070149787-A1 | Process for producing 2-acylthiophene compound | AGPAT2, MOGAT2, TPST2 | HPGD 2748/4885LMNA 4557/4885ALDH1A1 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.